Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer

Affiliations

¹ The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
² Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
³ Faculty of Medicine, Université de Genève, Geneva, Switzerland.
⁴ Cancer Research UK Scotland Institute, Glasgow, UK.
⁵ Centre for Human Genetics, University of Oxford, Oxford, UK.
⁶ Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
⁷ Department of Oncology, University of Torino, Candiolo, Torino, Italy.
⁸ School of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Belfast, UK.
⁹ Department of Oncology, University of Oxford, Oxford, Oxfordshire, UK.
¹⁰ Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
¹¹ School of Cancer Sciences, University of Glasgow, Glasgow, UK.
¹² Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK.
¹³ Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
¹⁴ The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. p.dunne@qub.ac.uk.
¹⁵ Cancer Research UK Scotland Institute, Glasgow, UK. p.dunne@qub.ac.uk.

^# Contributed equally.

Published Erratum

Sudhir B Malla et al. Nat Genet. 2024 Jun.

. 2024 Jun;56(6):1321.

doi: 10.1038/s41588-024-01809-4.

¹ The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
² Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
³ Faculty of Medicine, Université de Genève, Geneva, Switzerland.
⁴ Cancer Research UK Scotland Institute, Glasgow, UK.
⁵ Centre for Human Genetics, University of Oxford, Oxford, UK.
⁶ Candiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
⁷ Department of Oncology, University of Torino, Candiolo, Torino, Italy.
⁸ School of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Belfast, UK.
⁹ Department of Oncology, University of Oxford, Oxford, Oxfordshire, UK.
¹⁰ Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
¹¹ School of Cancer Sciences, University of Glasgow, Glasgow, UK.
¹² Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK.
¹³ Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
¹⁴ The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. p.dunne@qub.ac.uk.
¹⁵ Cancer Research UK Scotland Institute, Glasgow, UK. p.dunne@qub.ac.uk.

^# Contributed equally.

No abstract available

Erratum for

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Malla SB, Byrne RM, Lafarge MW, Corry SM, Fisher NC, Tsantoulis PK, Mills ML, Ridgway RA, Lannagan TRM, Najumudeen AK, Gilroy KL, Amirkhah R, Maguire SL, Mulholland EJ, Belnoue-Davis HL, Grassi E, Viviani M, Rogan E, Redmond KL, Sakhnevych S, McCooey AJ, Bull C, Hoey E, Sinevici N, Hall H, Ahmaderaghi B, Domingo E, Blake A, Richman SD, Isella C, Miller C, Bertotti A, Trusolino L, Loughrey MB, Kerr EM, Tejpar S; S:CORT consortium; Maughan TS, Lawler M, Campbell AD, Leedham SJ, Koelzer VH, Sansom OJ, Dunne PD. Malla SB, et al. Nat Genet. 2024 Mar;56(3):458-472. doi: 10.1038/s41588-024-01654-5. Epub 2024 Feb 13. Nat Genet. 2024. PMID: 38351382 Free PMC article.